Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 2


Figure 2 Recombinant Human Antibodies to MDA–apoB-100 Peptides Upregulate ABCA-1 Expression In Vivo and In Vitro

(A) ABCA-1 staining of aortic arch plaques from FITC-8–, IEI-E3–, and 2D03-treated mice. (B) The values represent the percentages of ABCA-1–stained area per total plaque area. (C) Flow cytometry histogram showing ABCA-1 expression of untreated (gray shaded peak), FITC-8–treated (black line overlay), and 2D03-treated (red line overlay) cells. (D) Mean ABCA-1 expression of untreated and FITC-8– and 2D03-treated cells. The values are expressed as percentages of mean fluorescent intensity of the untreated control. Scale bar = 100 µm. *p < 0.02 and **p < 0.01 versus FITC-8. ABCA-1 = adenosine triphosphate–binding cassette transporter A1; apoB-100 = apolipoprotein B-100; FITC-8 = fluorescein isothiocyanate-8; MDA = malondialdehyde.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement